ArticleThe Journal of clinical endocrinology and metabolism2014

Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.

Hong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.